GS vs CME stock comparison
Goldman Sachs Group vs. CME Group · data as of November 13, 2026
Goldman Sachs Group (GS) has a market value of about $264.4B, CME Group (CME) about $113.8B. Over their latest twelve months Goldman Sachs Group had revenue of $69.7B and CME Group $7.0B.
On our five checks CME Group scores higher: 2.4 out of 5 (weak) against 2.2 (weak).
By area, the stronger company is Goldman Sachs Group on value; CME Group on future growth; CME Group on financial health.
Goldman Sachs Group is cheaper on earnings (P/E 13.2 vs. 26.1), while CME Group grew revenue faster over five years (5.9% vs. 5.5% a year).
Goldman Sachs Group leads on 13 of the compared lines and CME Group on 7.
Side by side
| GS | CME | |
|---|---|---|
| Size and price | ||
| Market cap | $264.4B | $113.8B |
| Share price | $916.56 | $317.97 |
| Score | ||
| Overall score (of 5) | 2.2 | 2.4 |
| Value | 4 | 0 |
| Future growth | 1 | 2 |
| Track record | 2 | 2 |
| Financial health | 0 | 4 |
| Shareholder returns | 4 | 4 |
| Valuation | ||
| P/E (TTM) | 13.2 | 26.1 |
| Forward P/E | 12.7 | 24.5 |
| Price / free cash flow | — | 26.3 |
| Price / sales | 3.8 | 16.3 |
| EV / EBITDA | 5.5 | 24.6 |
| PEG | 0.84 | 1.90 |
| DCF value vs. price | +28% | −41% |
| Business | ||
| Revenue | $69.7B | $7.0B |
| Net income | $21.3B | $4.4B |
| Free cash flow | -$40.0B | $4.3B |
| Net margin | 30.6% | 63.3% |
| Gross margin (5-yr avg.) | — | — |
| ROIC (5-yr avg.) | — | 8.7% |
| Growth | ||
| Revenue growth (1 yr) | 8.9% | 6.4% |
| Revenue growth (5 yrs, per year) | 5.5% | 5.9% |
| EPS growth (5 yrs, per year) | 15.7% | 13.7% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$270.1B | -$1.5B |
| Dividend yield | 2.18% | 1.64% |
| Shareholder yield | 6.9% | 1.6% |
| Analysts | ||
| Upside to average target | +12% | −0% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: GS TTM to September 30, 2026, CME TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Goldman Sachs Group or CME Group?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) CME Group scores 2.4 out of 5 and Goldman Sachs Group 2.2; the table shows where each one is stronger.
Is Goldman Sachs Group cheaper than CME Group?
On trailing earnings, Goldman Sachs Group trades at a P/E of 13.2 and CME Group at 26.1, so Goldman Sachs Group is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Goldman Sachs Group or CME Group?
Over five years CME Group grew revenue about 5.9% a year and Goldman Sachs Group about 5.5% a year.
Which pays a higher dividend?
Goldman Sachs Group yields 2.18% and CME Group 1.64%.
Full Goldman Sachs Group analysis → Full CME Group analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.